Floatz logo

Drospirenone

Menstrual Irregularities

Tyumen State Medical AcademySmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Menstrual Irregularities cohort.

Asset / SponsorPhaseRating
Selmevit
Tyumen State Medical Academy
Phase 4BB
CYPROTERONE
Tyumen State Medical Academy
Phase 4BB
ORSYTHIA COMPONENT ETHINYL ESTRADIOL
Tyumen State Medical Academy
Phase 4BB

Same molecule, other indications

Drospirenone is also rated in:

polycystic ovary syndromeDormant
BBB
Indicative ·
78 / 100
View asset →
HyperandrogenismDormant
BB
Indicative ·
65 / 100
View asset →
polycystic ovary syndromeDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →